These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18709573)

  • 41. Defining, explaining and understanding hormesis.
    Kitchin KT
    Hum Exp Toxicol; 2002 Feb; 21(2):105-6; discussion 113-4. PubMed ID: 12102493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dominance as adaptive stressing and ranking of males, serving to allocate reproduction by differential self-suppressed fertility: towards a fully biological understanding of social systems.
    Moxon S
    Med Hypotheses; 2009 Jul; 73(1):5-14. PubMed ID: 19375872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The search for hormesis in the nervous system.
    Diamond DM
    Crit Rev Toxicol; 2008; 38(7):619-22. PubMed ID: 18709569
    [No Abstract]   [Full Text] [Related]  

  • 44. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of the cutoff value in the quadratic adaptive integrate-and-fire model.
    Touboul J
    Neural Comput; 2009 Aug; 21(8):2114-22. PubMed ID: 19409056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comments on the article 'Defining hormesis', by EJ Calabrese and LA Baldwin.
    Upton AC
    Hum Exp Toxicol; 2002 Feb; 21(2):111; discussion 113-4. PubMed ID: 12102495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hormesis and toxic torts.
    Marchant GE
    Hum Exp Toxicol; 2008 Feb; 27(2):97-107. PubMed ID: 18480129
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethical principles for hormesis policies.
    Hansson S
    Hum Exp Toxicol; 2008 Aug; 27(8):609-12. PubMed ID: 19029256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormetic responses in neural systems: consideration, contexts, and caveats.
    Giordano J; Ives JA; Jonas WB
    Crit Rev Toxicol; 2008; 38(7):623-7. PubMed ID: 18709570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Model-based evaluation of QTc interval risk: an increasing emphasis on early decision making.
    Krishna R
    J Clin Pharmacol; 2009 Sep; 49(9):1010-1. PubMed ID: 19717724
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hypothesis: An alternative pathway for the regulation of inflammation. Hormesis and inflammation].
    Orden AO
    Medicina (B Aires); 2005; 65(1):87-8. PubMed ID: 15830801
    [No Abstract]   [Full Text] [Related]  

  • 53. Hormesis without cell killing.
    Cox LA
    Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Defining hormesis: evaluation of a complex concentration response phenomenon.
    Kendig EL; Le HH; Belcher SM
    Int J Toxicol; 2010; 29(3):235-46. PubMed ID: 20448256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How does pain affect jaw muscle activity? The Integrated Pain Adaptation Model.
    Peck CC; Murray GM; Gerzina TM
    Aust Dent J; 2008 Sep; 53(3):201-7. PubMed ID: 18782363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Commentary on "Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses" by Edward J. Calabrese.
    Talsness CE; Chahoud I
    Crit Rev Toxicol; 2005 Jul; 35(6):599-601. PubMed ID: 16422397
    [No Abstract]   [Full Text] [Related]  

  • 59. Mammogram and diagnostic X-rays--evidence of protective Bystander, Adaptive Response (AR) radio-protection and AR retention at high dose levels.
    Leonard BE; Leonard VF
    Int J Radiat Biol; 2008 Nov; 84(11):885-99. PubMed ID: 19016137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adaptive response in the different mitotic cycles after irradiation].
    Pelevina II; Aleshchenko AV; Antoshchina MM; Boeva OV; Gotlib VIa; Kudriashova OV; Lizunova EIu; Osipov AN; Riabchenko NI; Semenova LP; Serebrianyĭ AM
    Tsitologiia; 2009; 51(1):78-83. PubMed ID: 19281051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.